BTMD - NASDAQ

biote Corp.

biote Corp.

BTMD·NASDAQ

$2.11

+5.5%
HealthcareMedical - Care Facilities

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$93.07M
EPS0.8600
P/E Ratio2.45
Earnings Date08/05/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

biote Corp.

biote Corp. Earnings Call Transcripts

BTMD · NASDAQ

Related Guides

Blog Categories

Continue your BTMD research with focused valuation guides.

Forecasting

Compare management guidance with modeled outcomes.

Risk Analysis

Track estimate risk, misses, and downside scenarios.

Reference

Review analyst process and transcript interpretation.

Value Investing

Anchor quarterly narrative to intrinsic value discipline.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.